HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Orajel Ultra Mouth Sore "Film-Forming Gel" TV Ads Slated For February

This article was originally published in The Tan Sheet

Executive Summary

Del Pharmaceuticals Orajel Ultra Mouth Sore Medicine, which provides "immediate pain relief" while creating a "film-forming gel" to protect canker sores from irritation, will begin appearing on store shelves this month, the company said.

You may also be interested in...



Del Labs

Orajel and cosmetics drove up net sales 20.2% to $77.7 mil. for the third quarter, company says Oct. 26. Net income for the quarter was $1.2 mil., compared to a $6.1 mil. loss in the year-ago period. Nine-month sales totaled $221.7 mil., a 12.6% increase from the prior-year period. Ads for Orajel Ultra Mouth Sore Medicine, which shipped at the end of the quarter, are slated for February 2001 (1"The Tan Sheet" Oct. 9, p. 5)

Closure Medical Liquiderm Approval Could Be Seen By Year-End

Initial clinical data evaluating Closure Medical's Liquiderm nonabsorbable liquid adhesive bandage suggest the cyanoacrylate-based product reduces pain, seals wounds from infection and adheres to wounds better than traditional bandages, the firm maintained.

Heritage Eucalyptamint 2000 Arthritis Pain Relief Gel Debuting In June

Heritage Consumer Products has begun shipping the topical arthritis pain relief gel Eucalyptamint 2000 to food, drug and mass market outlets nationwide. The move anticipates the product's launch in June.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS133765

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel